EDGAR Filing Documents for 0001558370-24-002267

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001558370-24-002267

Filing Date

2024-03-01

Accepted

2024-03-01 16:31:02

Documents

120

Period of Report

2023-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	tbph-20231231x10k.htm iXBRL	10-K	2994837
2	EX-10.39	tbph-20231231xex10d39.htm	EX-10.39	21804
3	EX-21.1	tbph-20231231xex21d1.htm	EX-21.1	3296
4	EX-23.1	tbph-20231231xex23d1.htm	EX-23.1	4224
5	EX-31.1	tbph-20231231xex31d1.htm	EX-31.1	10370
6	EX-31.2	tbph-20231231xex31d2.htm	EX-31.2	10377
7	EX-32	tbph-20231231xex32.htm	EX-32	14980
8	EX-97.1	tbph-20231231xex97d1.htm	EX-97.1	42267
9	GRAPHIC	tbph-20231231x10k006.jpg	GRAPHIC	31608
10	GRAPHIC	tbph-20231231x10k007.jpg	GRAPHIC	20034
11	GRAPHIC	tbph-20231231x10k008.jpg	GRAPHIC	3307
12	GRAPHIC	tbph-20231231x10k009.jpg	GRAPHIC	10473
13	GRAPHIC	tbph-20231231xex10d39001.jpg	GRAPHIC	8090
14	GRAPHIC	tbph-20231231xex10d39002.jpg	GRAPHIC	631
15	GRAPHIC	tbph-20231231xex10d39003.jpg	GRAPHIC	631
16	GRAPHIC	tbph-20231231xex10d39004.jpg	GRAPHIC	631
	Complete submission text file	0001558370-24-002267.txt		13673410

Data Files

Seq	Description	Document	Type	Size
17	EX-101.SCH	tbph-20231231.xsd	EX-101.SCH	89264
18	EX-101.CAL	tbph-20231231_cal.xml	EX-101.CAL	81008
19	EX-101.DEF	tbph-20231231_def.xml	EX-101.DEF	432375
20	EX-101.LAB	tbph-20231231_lab.xml	EX-101.LAB	760213
21	EX-101.PRE	tbph-20231231_pre.xml	EX-101.PRE	640375
122	EXTRACTED XBRL INSTANCE DOCUMENT	tbph-20231231x10k_htm.xml	XML	2510867

Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104

Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000

Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)